Overview
Vertex Pharmaceuticals is a Boston biotechnology company that discovers, develops, manufactures and commercialises small-molecule drugs for serious diseases, with a principal focus on cystic fibrosis.[2] Forbes records sales of US$12.3bn, up 12.4%, and profit of US$4.3bn, a margin of 35%, second only to Novo Nordisk in this ranking.[2] With 6,400 employees it is the smallest workforce in the list, and it produces more sales per employee (about US$1.9m) than any other company in the top 25. Its market value of US$110.9bn is higher than those of GSK and Sanofi, both of which have more than three times its sales.[2] Forbes records it as founded by Joshua S. Boger in 1989.[2]
Vertex Pharmaceuticals strengths and limitations
Strengths
- Profit margin of 35%
- Highest sales per employee in the list
- Market value above US$100bn
Limitations
- Revenue concentrated in cystic fibrosis
- Smallest company in the ranking
- Diversification efforts still early
Appears in
Vertex Pharmaceuticals peers and competitors
Companies ranked in the same lists as Vertex Pharmaceuticals.
Johnson & Johnson- Amgen
- Astellas Pharma
Viatris- Regeneron Pharmaceuticals
- CSL
Otsuka Holdings- Teva Pharmaceutical
Merck KGaA
Gilead Sciences
Takeda Pharmaceutical
GSK plc
Is this your company?
Update the description, logo, image and link through the submission form. Editors review every change.